UHS Stock Analysis: Buy, Sell, or Hold?
UHS - Universal Health Services, Inc. Class B
$145.85
3.21 (2.25%)
▲
5d:
-0.08%
30d:
-10.22%
90d:
-22.46%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Jul 27, 2026
Get Alerted When UHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: UHS trading at deep discount. Market pricing in -9.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: UHS trading at deep discount. Market pricing in -9.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$266.94
Based on 6.2% avg growth
INTRINSIC VALUE TODAY
$165.75
12.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UHS is currently trading at $145.85, which is considered oversold relative to its 30-day fair value range of $142.84 to $164.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.8) compared to its historical average (7.8). Remarkably, the market is currently pricing in an annual earnings decline of 9.8% over the next few years. This pessimistic expectation contrasts with the company's recent 17.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UHS is in a strong downtrend. Immediate support is located at $140.08, while resistance sits at $159.52.
Market Sentiment: UHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $215.76 (+47.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UHS is in a strong downtrend. Immediate support is located at $140.08, while resistance sits at $159.52.
Market Sentiment: UHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $215.76 (+47.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$142.84 -
$164.22
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
90.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 47.9% below Wall St target ($215.76)
Trading Range Analysis
30-Day Trading Range
$142.84 -
$164.22
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$140.08
Resistance Level
$159.52
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.75
Wall Street Target
$215.76
(+47.9%)
Revenue Growth (YoY)
9.6%
Earnings Growth (YoY)
17.7%
Profit Margin
8.6%
Valuation Discount vs History
-9.8% cheaper
PE vs Historical
5.8 vs 7.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.8%
(market-implied from PE analysis)
1-Year Target
$131.56
(-10%)
2-Year Target
$118.66
(-19%)
3-Year Target
$107.04
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→8)
$145.09
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.4%)
$702.38
(+382%)
Base:
(SPY PE: 5.8, Growth: 8.4%)
$185.56
(+27%)
Bear:
(PE: 4.9, Growth: 8.4%)
$157.73
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (6x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 5.96 | Current EPS (TTM): $23.95
Bull Case
$166.06
(+14%)
Analyst growth 5.8%, PE expands to 6.6
Base Case
$150.96
(+4%)
Market implied 5.8%, PE stable at 6.0
Bear Case
$96.99
(-34%)
Severe decline -20.0%, PE contracts to 5.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.8 to 7.8
Stabilization Target:
$197.71
(+35.6%)
PE Expansion Potential:
+35.6%
Share & Embed Analysis
Last updated: June 23, 2026 11:39 PM ET
Data refreshes hourly during market hours. Next update: 12:39 AM
Data refreshes hourly during market hours. Next update: 12:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UHS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-01-29
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 58 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 HOLD |
Advanced UHS Option Strategies
Professional options setups generated by AI based on today's UHS price and gamma walls.
